Just sent an email to the editor to correct. “H
Post# of 36537
(Total Views: 341)
Posted On: 05/28/2020 6:39:25 PM
Just sent an email to the editor to correct.
“Hello,
In today’s article by Tom Bawden, the company information for Dr Eric von Hofe is incorrect. Dr von Hofe is Chief Scientific Officer for NuGenerex Immuno-oncology, div of Generex Biotechnology (GNBT). Please update. Thank you. https://generex.com/nugenerex-family-of-companies
“ Last month, Eric von Hofe, chief scientific officer of the UK drugs company, said:“By definition, a pandemic spans multiple different regulatory jurisdictions."””
“Hello,
In today’s article by Tom Bawden, the company information for Dr Eric von Hofe is incorrect. Dr von Hofe is Chief Scientific Officer for NuGenerex Immuno-oncology, div of Generex Biotechnology (GNBT). Please update. Thank you. https://generex.com/nugenerex-family-of-companies
“ Last month, Eric von Hofe, chief scientific officer of the UK drugs company, said:“By definition, a pandemic spans multiple different regulatory jurisdictions."””
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼